Showing results (141-150 of 303) with videos related to
Sort By:
Pageof 31
Clinical & Translational Immunology|May 16, 2022
Off-target effects of bacillus Calmette-Guérin vaccination on immune responses to SARS-CoV-2: implications for protection against severe COVID-19Nicole L Messina, Susie Germano, Rebecca McElroy, et al.Journal of Virology|October 20, 2017
In Vitro Neutralization Is Not Predictive of Prophylactic Efficacy of Broadly Neutralizing Monoclonal Antibodies CR6261 and CR9114 against Lethal H2 Influenza Virus Challenge in MiceTroy C Sutton, Elaine W Lamirande, Kevin W Bock, et al.Journal of Virology|April 29, 2005
Evaluation of human monoclonal antibody 80R for immunoprophylaxis of severe acute respiratory syndrome by an animal study, epitope mapping, and analysis of spike variantsJianhua Sui, Wenhui Li, Anjeanette Roberts, et al.Journal of Virology|November 11, 2011
Molecular determinants of severe acute respiratory syndrome coronavirus pathogenesis and virulence in young and aged mouse models of human diseaseMatthew Frieman, Boyd Yount, Sudhakar Agnihothram, et al.Paediatric Respiratory Reviews|March 1, 2022
Age-related differences in SARS-CoV-2 binding factors: An explanation for reduced susceptibility to severe COVID-19 among children?Thomas Abrehart, Randy Suryadinata, Conor McCafferty, et al.Viruses|August 28, 2021
Prevalence of Neutralising Antibodies to HCoV-NL63 in Healthy Adults in AustraliaSean A Lynch, Kanta Subbarao, Siddhartha Mahanty, et al.Journal of Virology|August 21, 2009
A single-amino-acid substitution in a polymerase protein of an H5N1 influenza virus is associated with systemic infection and impaired T-cell activation in miceJamie L Fornek, Laura Gillim-Ross, Celia Santos, et al.Plos Medicine|April 22, 2009
Antigenic fingerprinting of H5N1 avian influenza using convalescent sera and monoclonal antibodies reveals potential vaccine and diagnostic targetsSurender Khurana, Amorsolo L Suguitan, Yonaira Rivera, et al.Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|September 14, 2023
The re-emergence of influenza following the COVID-19 pandemic in Victoria, Australia, 2021 to 2022Catherine Ga Pendrey, Janet Strachan, Heidi Peck, et al.Emerging Infectious Diseases|July 27, 2002
DNA vaccine expressing conserved influenza virus proteins protective against H5N1 challenge infection in miceSuzanne L Epstein, Terrence M Tumpey, Julia A Misplon, et al.Pageof 31